Over the past years of my research and personal investment in understanding autism, I’ve come to appreciate how complex and multifaceted neurodivergence is, especially when considering the biochemical and pathological underpinnings. In 2023, I developed a theoretical model on the pathology of autism and its comorbidities that is gaining recognition, as some esteemed institutions like Princeton, Stanford, Harvard, and Yale have independently validated aspects of it. The process of formalizing this work has been intense but rewarding, including filing for copyrights and registering trademarks such as NeuroToggle and BioToggle, which represent innovative tools or concepts linked to this theory. This journey also involved professionalizing my online presence, including updating my website and carefully curating my social media to reflect the evolving scope of my work and findings. The silence I am taking now is a deliberate pause to consolidate what I’ve built privately and prepare for the next phase, which might surprise some followers but reflects years of careful development. Sharing this experience, I realize how vital it is for those involved in neurodivergent research or personal neurodivergent journeys to stay adaptable and patient, as progress often happens away from the spotlight. It’s also a reminder of the significant behind-the-scenes effort required to transition from theory to practical, recognized contributions in the field. For anyone exploring similar domains, the key is to maintain focus on evidence-based findings, professional growth, and readiness to evolve your approach as new data and validations emerge.